Genetically modified model organisms are valuable tools for probing gene function, dissecting complex signaling networks, studying human disease, and more. CRISPR/Cas9 technology has significantly democratized and reduced the time and cost of generating genetically modified models to the point that small gene edits are now routinely and efficiently generated in as little as two months. However, generation of larger and more sophisticated gene-modifications continues to be inefficient. Alternative ways to provide the replacement DNA sequence, method of Cas9 delivery, and tethering the template sequence to Cas9 or the guide RNA (gRNA) have all been tested in an effort to maximize homology-directed repair for precise modification of the genome. We present two CRISPR/Cas9 methods that have been used to successfully generate large and complex gene-edits in mouse. In the first method, the Cas9 enzyme is used in conjunction with two sgRNAs and a long single-stranded DNA (lssDNA) template prepared by an alternative protocol. The second method utilizes a tethering approach to couple a biotinylated, double-stranded DNA (dsDNA) template to a Cas9-streptavidin fusion protein.
Method details

Animal use
All animal experiments were performed following Portuguese (Portaria 1005/95) and European (Directive 2010/63/EU) legislations regarding housing, husbandry, and welfare. This project received review and approval by the Ethics committee of Instituto Gulbenkian de Ciência and by the Portuguese National Entity, Direcção Geral de Alimentação Veterinária (license reference: 014308). a Proper mixing will ensure that all traces of DNA template are removed.
3 Save 2 ml of the solution (Sample 1) before adding the E-PAP reagent.
4 Incubate with the Poly(A) tailing reagents for 30 min at 37 C. 5 Save 2 ml of the solution (Sample 2) after completing the Poly(A) tailing procedure. a Dilute both reserved samples with 9 ml of water and add RNase-free gel loading dye.
b Run samples on a 0.8% agarose gel to determine if Poly(A) tailing was successful ( Fig. 1) .
Clean Cas9 or Cas9-streptavidin mRNA: RNeasy Mini Kit. Follow the manufacturer's protocol with the following notes:
1 Elute in 40 ml of RNase-free water instead of provided elution buffer.
2 Measure the concentration of the eluted RNA on a NanoDrop of similar.
3 Run 200-500 ng of mRNA on a 0.8% agarose gel (Sample 3) to confirm that it has not degraded during the cleaning procedure ( Fig. 1 ). 4 Store mRNA at -80 C. a NOTE: Aliquot into smaller volumes and avoid freeze-thaw cycles which might degrade the product. Run a small amount of mRNA on a gel prior to every experiment to insure product has not degraded. a Basic reaction conditions:Plasmid25 mg10x Enzyme Buffer5 mlRestriction Enzyme2-3mlWaterto 50 ml b NOTE: Obtain a large amount of plasmid through standard midi-prep or maxi-prep procedures. c NOTE: Restriction enzyme should linearize the plasmid immediately after the sgRNA scaffold within the plasmid. This allows for "run off" transcription. It is possible to use an enzyme that cuts multiple times within the plasmid backbone as long as it generates a linear piece of plasmid containing the T7 priming site and the entire sgRNA scaffold. 2 Run a small amount (200 ng) of the cleaned restriction digest on a 0.8% agarose gel to confirm plasmid was properly linearized.
3 Add 50 ml of DNase/RNase-free water to bring the reaction to 100 ml. 4 Add 100 ml of phenol/chloroform and shake vigorously until reaction becomes opaque.
5 Spin solution at maximum speed for 5 min at room temperature. 6 Carefully remove the upper, aqueous layer of the reaction and move to a new tube. a NOTE: it is very important to avoid contamination with the lower layer. Cleaning sgRNA transcript: MEGAclear transcription clean-up kit. Follow the manufacturer's protocol with the following notes 1 Make sure all centrifugation steps do not exceed an RCF of 15,000xg. This will prevent damage to the spin columns.
2 Use RNA elution option 1. Elute in 50 ml of DNase/RNase-free water and not the provided elution buffer. Incubate at 70 C in a heat block for 10 min. 3 Do not repeat the elution procedure as suggested by the manufacturer. In our hands this does not increase the RNA yields significantly and reduces final sgRNA concentration. 4 Following cleaning, measure the RNA concentration on NanoDrop or similar. 5 Run 500 ng on a 2% agarose gel to confirm production of a single sgRNA product (Fig. 2 ). a NOTE: In some cases the RNA might give two apparent products, one with the expected size and another a bit bigger. This pattern results from the RNA acquiring different conformations that run differently in the gel. 6 Store sgRNA at -80 C a NOTE: Aliquot into smaller volumes and avoid freeze-thaw cycles which might degrade the product. Run a small amount of sgRNA on a gel prior to every experiment to insure product has not degraded. a NOTE: Use of a proof-reading enzyme is essential to reduce the probability of introducing mutations. b NOTE: Minimize the primer concentration as much as possible to allow for more efficient oligo removal during step 3.
c NOTE: Check PCR reaction by running a small amount (2-5 ml of the reaction) on an agarose gel to confirm reaction generates single PCR product. If reaction cannot be optimized to eliminate un-desired bands, proceed with a gel PCR purification method to obtain desired band. 3 Pool PCR reactions and clean using a column-based PCR purification system to remove the unused biotinylated primer that will interfere with the reaction in step 4. The typical elution volume is 50 ml. Elute in DNase/RNase-free water instead of provided elution buffer. a Reserve 2 ml of cleaned product to serve as a loading control (Sample 1).
b Calculate the total yield of purified DNA. This will be necessary to calculate the volume of beads necessary in step 4.
4 Wash Dynabeads MyOne Streptavidin C1 beads twice with 500 ml of Buffer A. Use 1.5 mL
Eppendorff tubes with a magnetic rack to precipitate beads. a Follow manufacturer's recommendations to determine volume of beads required to bind biotinylated DNA.
5 Dilute purified PCR product in 300 ml of Buffer A and incubate with streptavidin beads at room temperature for 1 h with rotation. a NOTE: For PCR products greater than 1 kb, increase the incubation time to several hours or to overnight to increase efficiency of biotin/streptavidin binding. 6 Collect beads using a magnetic rack and save the supernatant (Sample 2). This will be used to estimate the efficiency of biotin/streptavidin binding. a Add 30 ml of 3 M NaOAc, pH 5.3 and 900 ml of 100% ethanol and mix thoroughly.
b Place tubes on dry ice for at least 30 min. 11 Recover precipitated DNAs by centrifugation at maximum speed for 30 min at 4 C.
a Remove supernatant and allow DNA pellet to air-dry for 5-10 min or until any remaining liquid has evaporated.
b Resuspend Sample 2 in 5 ml of TE buffer or water. c Resuspend Sample 3 (ssDNA) in a small volume (11-15 ml) of RNase-free water.
d NOTE: Precipitated ssDNA frequently adheres to the tube wall along the entire vertical length instead of forming a pellet. To resuspend, use the pipette-tip to move the droplet of water along the tube. Liquid will form droplets along the tube. Recover the liquid with a short centrifugation and repeat the process until droplets no longer adhere to the tube wall, which means that the DNA is dissolved. Recover the whole volume with a short spin. 12 Measure the concentration of Sample 2 and Sample 3 on a NanoDrop or similar. 13 Run Samples 1-3 on a 1% agarose gel (Fig. 3) .
a Run 1-2 ml of Sample 3 (ssDNA).
b Try to use comparable amounts of all samples to improve comparison. c NOTE: ssDNA runs different from PCR products and signal can be difficult to detect using most gel visualization methods. 14 ssDNA can be stored at -20 C or -80 C.
D. Synthesis of biotinylated double stranded DNA (dsDNA)
Materials.
Targeting plasmid template Refer to supplemental information for further notes on design of targeting plasmid template Primer set for template generation (forward and reverse)
Both primers must contain a biotin modification on the 5 0 end. High Fidelity Taq Polymerase kit with proof-reading activity (e.g. HotStar HiFidelity Polymerase kit, Qiagen Cat. No. 202602) CRISPR/Cas9 reagents were injected into the pronuclei of fertilized oocytes using standard procedures [1] . Gene-editing can be assessed by PCR analysis and/or Southern Blotting as appropriate for the desired modification. NOTE: It is of critical importance to prepare all stock reagents (Cas9/Cas9-streptavidin mRNA, sgRNAs, and replacement DNA) as concentrated as possible. Thus, when reagents are diluted for microinjection, potential contaminants are diluted beyond detection and will not obstruct the injection needle.
Method validation
We have used both Method 1 and Method 2 to generate a diverse array of gene-edited mouse models including;
Conditional allele via simultaneous incorporation of two LoxP sites Gene swaps through removing and replacing the coding regions of Gene A with Gene B
For our gene editing strategies, potential sgRNAs are manually identified to generate a double strand break at the 5 0 and 3 0 boundaries of the region of DNA to be edited. It is important that the Cas9 generated cut site is as close as possible to the desired editing site to maximize the efficiency of homology directed repair. Thus, the relative number of potential sgRNAs to be considered will vary depending on the nature of the desired edit. Publically available online tools can be used to evaluate the potential efficiency of sgRNAs; however, Cas9-mediated cutting efficiency should be empirically determined for each sgRNA. After the sgRNA(s) have been validated, the targeting plasmid vector can be designed and generated using conventional cloning techniques or custom synthesized commercially. We use 100-200bp of flanking homology for both the ssDNA and biotinylated-dsDNA targeting methods. The size of the homology arm is based on evidence provided by other published CRISPR methodologies and experience in our laboratory [2] [3] [4] [5] . A targeting plasmid containing 300bp or more of flanking homology allows enough flexibility to pick optimal primer pairs for generating DNA templates.
The choice of using Method 1 or Method 2 must be determined empirically and will differ depending on the nature of the desired edit. We have successfully generated "floxed" alleles using Method 1; however, no evidence of editing was observed when we attempted to generate a gene swap (Fig. 4A ). Alternatively, we achieved very high gene editing efficiency when creating a complex gene swap using Method 2 (Fig. 4B ). It is important to note that the efficiency of gene editing will vary depending on the target locus and the nature of the edit being generated. Efficiency of editing also depends on the quality of the CRISPR reagents used for microinjection and it is of critical importance to insure that RNA based components show no signs of degradation prior to every round of microinjection.
Additional information
The commercial availability of CRISPR/Cas9 reagents and numerous advancements in efficiency of CRISPR-based gene editing have allowed this technology to be routinely used in laboratories throughout the life sciences and medicine disciplines. The generation of novel gene-edited mouse models is now substantially easier and faster than using conventional stem cell-based gene-editing technologies. CRISPR/Cas9 is now routinely used for the generation of point mutations, "indels" to create loss-of-function alleles, and insertion of DNA sequences including protein tags like FLAG or HA and fluorescent reporters like GFP [6, 7] . However, efficient editing and/or insertion of large sequences of DNA, even in the case of fluorescent reporters, remain a big challenge in the field.
Representative locations of PCR primers to generate a unique band if exon swap occurs (Analysis 1, green arrows and brackets) are shown in upper diagram, PCR primers to screen for complete exon swap (Analysis 2, blue arrows and brackets) are shown in lower diagram, expected band sizes are listed above gel images. Gels (right) show PCR analysis for exon swaps of 16 F0 animals. Black arrows on Analysis 2 gels show two animals targeted to homozygous efficiency. Boxed region, shown in higher magnification in inset, demonstrates banding patterns for wild type (WT), heterozygous (het), and homozygous (homo) targeted Exon 2 swap. Targeting plasmid (+) and wild type genomic DNA (WT) were used as controls. Short single-stranded oligodeoxynucleotides (ssODN) are routinely used as the template DNA sequence for introducing small modifications to the genome [8] [9] [10] . The main drawback to this method is commercial oligo synthesis has a maximum size of around 200bp from most vendors, which is insufficient for the generation of larger gene edits. Longer single-stranded DNA (lssDNA) fragments can now be synthesized up to 2 kb from some vendors, but these fragments can be costly to purchase and still may not be sufficient in size for all desired genome modifications. Miura et al previously described a two-step method for synthesizing lssDNA, coined ivTRT [4] . This method first involves the in vitro transcription of the targeting plasmid followed by reverse transcription of the RNA to generate the lssDNA. Here we provide an alternative method for generating lssDNA templates that does not require reverse transcribing DNA from an RNA template. With this methodology we have successfully generated lssDNA templates up to 3.5 kb in size. Importantly, we could insert simultaneously two LoxP sites in a given allele without the need of retargeting schemes to introduce the second LoxP site.
Several groups have explored methods to increase the efficiency of homology directed repair (HDR) though the active recruitment or tethering of the template DNA sequence to either Cas9 or the sgRNA [11] [12] [13] [14] . The Cas9 fusion protein to monomeric streptavidin used in Method 2 described here was initially developed to improve the efficiency of generating fluorescent reporter alleles [15] . They report targeting efficiencies up to 97% when using a single sgRNA, Cas9-streptavidin, and a biotinylated-dsDNA template to knock in a particular DNA sequence into a specific position in the genome. The main difference between this report and our method is the demonstration of effective targeting using two sgRNAs to replace a particular genomic sequence for another one (e.g. a gene or enhancer swap). In our hands, the use of two guides does not appear to interfere with homologous recombination or the orientation of the edited sequence, as might be predicted. This new method might prove particularly useful for generating alleles requiring gene-editing of large sequences of DNA.
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